Study of CD31 combined with D2-40 in peritoneal metastasis of synchronous colorectal cancer_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

ZHU Xinqiang ¹ ,  GUAN Wenxian ²

1. Department of General Surgery, Suqian People’s Hospital, Nanjing Drum Tower Hospital Group of Nanjing University Medical School, Suqian, Jiangsu 223800, P. R. China;
2. Department of General Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, P. R. China;

Corresponding?author：

GUAN Wenxian, Email: 15850502391@163.com

Keywords：

CD31; D2-40; synchronous colorectal cancer; peritoneal metastasis

DOI：

10.7507/1007-9424.201706085

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To detect expressions of CD31 and D2-40 in patients with simultaneous colorectal cancer with peritoneal metastasis and investigate their correlation between them. Method The expressions of CD31 and D2-40 protein in these 59 cases (there were 19 and 40 patients with or without peritoneal metastasis, respectively) of colorectal cancer were detected by immunohistochemical MaxVision method. Results ① The positive rates of CD31 and D2-40 protein expression in the colorectal cancer tissues with or without peritoneal metastasis were significantly higher than those of the normal colonic tissues (P<0.05), but which had no significant differences between the colorectal cancer tissues with or without peritoneal metastasis (P>0.05). ② The CD31 microvessel density (CD31-MVD) and D2-40 lymphatic microvessel density (D2-40-LMVD) in the colorectal cancer tissues with peritoneal metastasis were significantly higher than those of the normal colonic tissues (P<0.05) and the colorectal cancer tissues without peritoneal metastasis (P<0.05). ③ The CD31-MVD and D2-40-LMVD were not associated with all the clinicopathologic characteristics of the colorectal cancer patients without peritoneal metastasis (P>0.05), but which in the poorly differentiated adenocarcinoma and mucinous and signet ring cell carcinomas patients with peritoneal metastasis were significantly higher than those of the other types (P<0.05) and were not associated with the age, gender, and diamter of the tumor of it (P>0.05). ④ There was a positive correlation between the CD31-MVD and the D2-40-LMVD in the colorectal cancer patients with or without peritoneal metastasis (r=0.342, P=0.012; r=0.119, P=0.008). Conclusions CD31-MVD and D2-40-LMVD in colorectal cancer patients with peritoneal metastasis highly express and has a positive correlation, which means that they might have a certain relationship with peritoneal metastasis. There may be some common regulation way and collaboratively participate peritoneal metastasis of colorectal cancer.

Citation： ZHU Xinqiang, GUAN Wenxian. Study of CD31 combined with D2-40 in peritoneal metastasis of synchronous colorectal cancer. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2017, 24(12): 1473-1479. doi: 10.7507/1007-9424.201706085 Copy

1.	朱信強, 管文賢. 結直腸癌同時性腹膜轉移影響因素的多因素分析. 中國普外基礎與臨床雜志, 2016, 23(6): 696-701.
2.	王磊, 汪建平. 結直腸癌腹膜轉移的研究現狀及其爭議. 中華實驗外科雜志, 2014, 31(2): 234-235.
3.	Choi WW, Lewis MM, Lawson D, et al. Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression. Mod Pathol, 2005, 18(1): 143-152.
4.	Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat, 1995, 36(2): 169-180.
5.	唐穎, 王清峙, 趙然旭, 等. D2-40 和 CD31 在心海綿狀血管瘤和淋巴管瘤中的表達及其鑒別診斷意義. 診斷病理學雜志, 2015, 22(1): 27-29.
6.	徐國萍, 張林, 苗杰, 等. 微血管密度與 CD105、CD31 在胃癌中的表達及意義. 胃腸病學和肝病學雜志, 2009, 18(6): 524-526.
7.	Newman DK, Fu G, Adams T, et al. The adhesion molecule PECAM-1 enhances the TGF-β-mediated inhibition of T cell function. Sci Signal, 2016, 9(418): ra27.
8.	Deliu IC, Neagoe CD, Bezn? M, et al. Correlations between endothelial cell markers CD31, CD34 and CD105 in colorectal carcinoma. Rom J Morphol Embryol, 2016, 57(3): 1025-1030.
9.	Woodfin A, Voisin MB, Nourshargh S. PECAM-1: a multi-functional molecule in inflammation and vascular biology. Arterioscler Thromb Vasc Biol, 2007, 27(12): 2514-2523.
10.	Bazzoni G. Pathobiology of junctional adhesion molecules. Antioxid Redox Signal, 2011, 15(5): 1221-1234.
11.	Kuzu I, Bicknell R, Harris AL, et al. Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumours. J Clin Pathol, 1992, 45(2): 143-148.
12.	姜乃光, 陳曉江, 黃鶯, 等. 胃癌 i-67 和 CD31 表達的免疫組化研究. 中國現代藥物應用, 2009, 3(23): 94-95.
13.	李英, 張冬婭, 王艷芳, 等. 結直腸腺癌中 D2-40、CD34、VEGF 的表達及臨床意義. 臨床與實驗病理學雜志, 2010, 26(2): 231-233.
14.	Kim OH, Kang GH, Noh H, et al. Proangiogenic TIE2(+)/CD31 (+) macrophages are the predominant population of tumor-associated macrophages infiltrating metastatic lymph nodes. Mol Cells, 2013, 36(5): 432-438.
15.	牟江洪, 閻曉初, 李增鵬, 等, 結直腸癌淋巴管生成的特點及其臨床病理意義. 中華病理學雜志, 2005, 34(6): 348-352.
16.	Toll A, Gimeno-Beltrán J, Ferrandiz-Pulido C, et al. D2-40 immunohistochemical overexpression in cutaneous squamous cell carcinomas: a marker of metastatic risk. J Am Acad Dermatol, 2012, 67(6): 1310-1318.
17.	Jeon SR, Cho JY, Bok GH, et al. Does immunohistochemical staining have a clinical impact in early gastric cancer conducted endoscopic submucosal dissection? World J Gastroenterol, 2012, 18(33): 4578-4584.
18.	Yonemura Y, Endou Y, Tabachi K, et al. Evaluation of lymphatic invasion in primary gastric cancer by a new monoclonal antibody, D2-40. Hum Pathol, 2006, 37(9): 1193-1199.
19.	Takanami I. Lymphatic microvessel density using D2-40 is associated with nodal metastasis in non-small cell lung cancer. Oncol Rep, 2006, 15(2): 437-442.
20.	孫建軍, 經巍, 倪艷艷, 等. 一種新的人結腸腺癌淋巴管生成裸鼠動物模型. 外科研究與新技術, 2012, 1(1): 49-55.
21.	Dimova I, Popivanov G, Djonov V. Angiogenesis in cancer—general pathways and their therapeutic implications. J BUON, 2014, 19(1): 15-21.
22.	Cacchi C, Arnholdt HM, J?hnig H, et al. Clinical significance of lymph vessel density in T3 colorectal carcinoma. Int J Colorectal Dis, 2012, 27(6): 721-726.
23.	Straume O, Jackson DG, Akslen L. AIndependent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin Cancer Res, 2003, 9(1): 250-256.
24.	Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis—correlation in invasive breast carcinoma. N Engl J Med, 1991, 324(1): 1-8.
25.	Weidner N. Tumor angiogenesis: review of current applications in tumor prognostication. Semin Diagn Pathol, 1993, 10(4): 302-313.
26.	岳彩霞, 馬驥, 周海俊, 等. 蛋白酶體抑制劑 MG132 對 RhoA 誘導的腫瘤血管生成的抑制作用的研究. 四川大學學報(醫學版), 2011, 42(4): 445-450.
27.	陸儉, 施琴, 陳康武, 等. 骶骨脊索瘤 CD40、PCNA、CD31 表達及其與腫瘤復發的相關性研究. 中國矯形外科雜志, 2011, 19(11): 1197-1200.
28.	Molavi D, Argani P. Distinguishing benign dissecting mucin (stromal mucin pools) from invasive mucinous carcinoma. Adv Anat Pathol, 2008, 15(1): 1-17.
29.	Legrier ME, de Pinieux G, Boyé K, et al. Mucinous differentiation features associated with hormonal escape in a human prostate cancer xenograft. Br J Cancer, 2004, 90(3): 720-727.
30.	Khattab AZ, Ahmed MI, Fouad MA, et al. Significance of p53 and CD31 in astrogliomas. Med Oncol, 2009, 26(1): 86-92.
31.	施華球, 鄢俊, 王祥財.VEGF-D 及其受體在結直腸癌中的表達及與淋巴管生成的關系. 山東醫藥, 2010, 50(1): 348-352.
32.	李鑫, 龍漢安, 肖秀麗, 等. D2-40 與 nm23 在結直腸癌中的表達及臨床病理意義的探討. 瀘州醫學院學報, 2014, 37(5): 456-460.
33.	田滿福, 韓波. 檢測 CA199、CA125、CA153 及 CEA 在腫瘤診斷中的意義. 臨床和實驗醫學雜志, 2010, 9(7): 483-485.

1. 朱信強, 管文賢. 結直腸癌同時性腹膜轉移影響因素的多因素分析. 中國普外基礎與臨床雜志, 2016, 23(6): 696-701.
2. 王磊, 汪建平. 結直腸癌腹膜轉移的研究現狀及其爭議. 中華實驗外科雜志, 2014, 31(2): 234-235.
3. Choi WW, Lewis MM, Lawson D, et al. Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression. Mod Pathol, 2005, 18(1): 143-152.
4. Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat, 1995, 36(2): 169-180.
5. 唐穎, 王清峙, 趙然旭, 等. D2-40 和 CD31 在心海綿狀血管瘤和淋巴管瘤中的表達及其鑒別診斷意義. 診斷病理學雜志, 2015, 22(1): 27-29.
6. 徐國萍, 張林, 苗杰, 等. 微血管密度與 CD105、CD31 在胃癌中的表達及意義. 胃腸病學和肝病學雜志, 2009, 18(6): 524-526.
7. Newman DK, Fu G, Adams T, et al. The adhesion molecule PECAM-1 enhances the TGF-β-mediated inhibition of T cell function. Sci Signal, 2016, 9(418): ra27.
8. Deliu IC, Neagoe CD, Bezn? M, et al. Correlations between endothelial cell markers CD31, CD34 and CD105 in colorectal carcinoma. Rom J Morphol Embryol, 2016, 57(3): 1025-1030.
9. Woodfin A, Voisin MB, Nourshargh S. PECAM-1: a multi-functional molecule in inflammation and vascular biology. Arterioscler Thromb Vasc Biol, 2007, 27(12): 2514-2523.
10. Bazzoni G. Pathobiology of junctional adhesion molecules. Antioxid Redox Signal, 2011, 15(5): 1221-1234.
11. Kuzu I, Bicknell R, Harris AL, et al. Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumours. J Clin Pathol, 1992, 45(2): 143-148.
12. 姜乃光, 陳曉江, 黃鶯, 等. 胃癌 i-67 和 CD31 表達的免疫組化研究. 中國現代藥物應用, 2009, 3(23): 94-95.
13. 李英, 張冬婭, 王艷芳, 等. 結直腸腺癌中 D2-40、CD34、VEGF 的表達及臨床意義. 臨床與實驗病理學雜志, 2010, 26(2): 231-233.
14. Kim OH, Kang GH, Noh H, et al. Proangiogenic TIE2(+)/CD31 (+) macrophages are the predominant population of tumor-associated macrophages infiltrating metastatic lymph nodes. Mol Cells, 2013, 36(5): 432-438.
15. 牟江洪, 閻曉初, 李增鵬, 等, 結直腸癌淋巴管生成的特點及其臨床病理意義. 中華病理學雜志, 2005, 34(6): 348-352.
16. Toll A, Gimeno-Beltrán J, Ferrandiz-Pulido C, et al. D2-40 immunohistochemical overexpression in cutaneous squamous cell carcinomas: a marker of metastatic risk. J Am Acad Dermatol, 2012, 67(6): 1310-1318.
17. Jeon SR, Cho JY, Bok GH, et al. Does immunohistochemical staining have a clinical impact in early gastric cancer conducted endoscopic submucosal dissection? World J Gastroenterol, 2012, 18(33): 4578-4584.
18. Yonemura Y, Endou Y, Tabachi K, et al. Evaluation of lymphatic invasion in primary gastric cancer by a new monoclonal antibody, D2-40. Hum Pathol, 2006, 37(9): 1193-1199.
19. Takanami I. Lymphatic microvessel density using D2-40 is associated with nodal metastasis in non-small cell lung cancer. Oncol Rep, 2006, 15(2): 437-442.
20. 孫建軍, 經巍, 倪艷艷, 等. 一種新的人結腸腺癌淋巴管生成裸鼠動物模型. 外科研究與新技術, 2012, 1(1): 49-55.
21. Dimova I, Popivanov G, Djonov V. Angiogenesis in cancer—general pathways and their therapeutic implications. J BUON, 2014, 19(1): 15-21.
22. Cacchi C, Arnholdt HM, J?hnig H, et al. Clinical significance of lymph vessel density in T3 colorectal carcinoma. Int J Colorectal Dis, 2012, 27(6): 721-726.
23. Straume O, Jackson DG, Akslen L. AIndependent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin Cancer Res, 2003, 9(1): 250-256.
24. Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis—correlation in invasive breast carcinoma. N Engl J Med, 1991, 324(1): 1-8.
25. Weidner N. Tumor angiogenesis: review of current applications in tumor prognostication. Semin Diagn Pathol, 1993, 10(4): 302-313.
26. 岳彩霞, 馬驥, 周海俊, 等. 蛋白酶體抑制劑 MG132 對 RhoA 誘導的腫瘤血管生成的抑制作用的研究. 四川大學學報(醫學版), 2011, 42(4): 445-450.
27. 陸儉, 施琴, 陳康武, 等. 骶骨脊索瘤 CD40、PCNA、CD31 表達及其與腫瘤復發的相關性研究. 中國矯形外科雜志, 2011, 19(11): 1197-1200.
28. Molavi D, Argani P. Distinguishing benign dissecting mucin (stromal mucin pools) from invasive mucinous carcinoma. Adv Anat Pathol, 2008, 15(1): 1-17.
29. Legrier ME, de Pinieux G, Boyé K, et al. Mucinous differentiation features associated with hormonal escape in a human prostate cancer xenograft. Br J Cancer, 2004, 90(3): 720-727.
30. Khattab AZ, Ahmed MI, Fouad MA, et al. Significance of p53 and CD31 in astrogliomas. Med Oncol, 2009, 26(1): 86-92.
31. 施華球, 鄢俊, 王祥財.VEGF-D 及其受體在結直腸癌中的表達及與淋巴管生成的關系. 山東醫藥, 2010, 50(1): 348-352.
32. 李鑫, 龍漢安, 肖秀麗, 等. D2-40 與 nm23 在結直腸癌中的表達及臨床病理意義的探討. 瀘州醫學院學報, 2014, 37(5): 456-460.
33. 田滿福, 韓波. 檢測 CA199、CA125、CA153 及 CEA 在腫瘤診斷中的意義. 臨床和實驗醫學雜志, 2010, 9(7): 483-485.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Study of CD31 combined with D2-40 in peritoneal metastasis of synchronous colorectal cancer

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content